메뉴 건너뛰기




Volumn 106, Issue 7, 2014, Pages

Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL CRAMP; ABDOMINAL PAIN; ANOREXIA; ARTICLE; BLOATING; CANCER GROWTH; CANCER PATIENT; CANCER RECURRENCE; CANCER THERAPY; CLINICAL TRIAL (TOPIC); COGNITIVE DEFECT; CONSENSUS; CONSTIPATION; DIARRHEA; DYSPNEA; EMOTION; FATIGUE; FEAR; FEMALE SEXUAL DYSFUNCTION; HUMAN; INDIGESTION; INSOMNIA; NAUSEA; NEUROPATHY; OVARY CANCER; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; SYMPTOMATOLOGY; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION; ANXIETY; CONSENSUS DEVELOPMENT; DECISION MAKING; ERECTILE DYSFUNCTION; HEALTH STATUS; LARGE INTESTINE; MALE; METHODOLOGY; NATIONAL HEALTH ORGANIZATION; PATHOPHYSIOLOGY; PATIENT SATISFACTION; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; REVIEW; SELF REPORT; SEVERITY OF ILLNESS INDEX; STANDARD; TREATMENT OUTCOME; UNITED STATES; URINE INCONTINENCE; URINE RETENTION; VISCERAL PAIN;

EID: 84905232661     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju132     Document Type: Article
Times cited : (90)

References (102)
  • 1
    • 84905245803 scopus 로고    scopus 로고
    • Reeve B, Mitchell S, Dueck A, et al. Recommended core set of symptoms to measure adult oncology treatment trials
    • Reeve B, Mitchell S, Dueck A, et al. Recommended core set of symptoms to measure adult oncology treatment trials.
  • 2
    • 0035488989 scopus 로고    scopus 로고
    • Symptom indexes to assess outcomes of treatment for early prostate cancer
    • Clark JA, Talcott JA. Symptom indexes to assess outcomes of treatment for early prostate cancer. Med Care. 2001;39(10):1118-1130.
    • (2001) Med Care , vol.39 , Issue.10 , pp. 1118-1130
    • Clark, J.A.1    Talcott, J.A.2
  • 3
    • 0033669409 scopus 로고    scopus 로고
    • Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer
    • Wei JT, Dunn RL, Litwin MS, et al. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56(6):899-905.
    • (2000) Urology , vol.56 , Issue.6 , pp. 899-905
    • Wei, J.T.1    Dunn, R.L.2    Litwin, M.S.3
  • 4
    • 0032109544 scopus 로고    scopus 로고
    • The UCLA Prostate Cancer Index: Development, reliability, and validity of a health-related quality of life measure
    • Litwin MS, Hays RD, Fink A, et al. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care. 1998;36(7):1002-1012.
    • (1998) Med Care , vol.36 , Issue.7 , pp. 1002-1012
    • Litwin, M.S.1    Hays, R.D.2    Fink, A.3
  • 5
    • 80051543868 scopus 로고    scopus 로고
    • Expanded prostate cancer index composite for clinical practice: Development and validation of a practical health related quality of life instrument for use in the routine clinical care of patients with prostate cancer
    • Chang P, Szymanski KM, Dunn RL, et al. Expanded prostate cancer index composite for clinical practice: development and validation of a practical health related quality of life instrument for use in the routine clinical care of patients with prostate cancer. J Urol. 2011;186(3):865-872.
    • (2011) J Urol , vol.186 , Issue.3 , pp. 865-872
    • Chang, P.1    Szymanski, K.M.2    Dunn, R.L.3
  • 6
    • 78149359366 scopus 로고    scopus 로고
    • Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring healthrelated quality of life among prostate cancer survivors
    • Szymanski KM, Wei JT, Dunn RL, et al. Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring healthrelated quality of life among prostate cancer survivors. Urology. 2010;76(5):1245-1250.
    • (2010) Urology , vol.76 , Issue.5 , pp. 1245-1250
    • Szymanski, K.M.1    Wei, J.T.2    Dunn, R.L.3
  • 7
    • 54449096532 scopus 로고    scopus 로고
    • An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancer
    • van Andel G, Bottomley A, Fosså SD, et al. An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer. 2008;44(16):2418-2424.
    • (2008) Eur J Cancer , vol.44 , Issue.16 , pp. 2418-2424
    • Van Andel, G.1    Bottomley, A.2    Fosså, S.D.3
  • 8
    • 34347336318 scopus 로고    scopus 로고
    • Psychometric properties of a prostate cancer radiation late toxicity questionnaire
    • Rodrigues G, Bauman G, Lock M, et al. Psychometric properties of a prostate cancer radiation late toxicity questionnaire. Health Qual Life Outcomes. 2007;5:29.
    • (2007) Health Qual Life Outcomes , vol.5 , pp. 29
    • Rodrigues, G.1    Bauman, G.2    Lock, M.3
  • 9
    • 40949147326 scopus 로고    scopus 로고
    • Quality of life and satisfaction with outcome among prostate-cancer survivors
    • Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358(12):1250-1261.
    • (2008) N Engl J Med , vol.358 , Issue.12 , pp. 1250-1261
    • Sanda, M.G.1    Dunn, R.L.2    Michalski, J.3
  • 10
    • 0035868771 scopus 로고    scopus 로고
    • Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer
    • Madalinska JB, Essink-Bot ML, de Koning HJ, et al. Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer. J Clin Oncol. 2001;19(6):1619-1628.
    • (2001) J Clin Oncol , vol.19 , Issue.6 , pp. 1619-1628
    • Madalinska, J.B.1    Essink-Bot, M.L.2    De Koning, H.J.3
  • 11
    • 80053110733 scopus 로고    scopus 로고
    • Factors predicting continence recovery 1 month after radical prostatectomy: Results of a multicenter survey
    • Gacci M, Carini M, Simonato A, et al. Factors predicting continence recovery 1 month after radical prostatectomy: results of a multicenter survey. Int J Urol. 2011;18(10):700-708.
    • (2011) J Urol , vol.18 , Issue.10 , pp. 700-708
    • Gacci, M.1    Carini, M.2    Simonato, A.3
  • 12
    • 34447094026 scopus 로고    scopus 로고
    • Impact of nerve sparing technique on patient selfassessed outcomes after radical perineal prostatectomy
    • discussion 492
    • Kübler HR, Tseng TY, Sun L, et al. Impact of nerve sparing technique on patient selfassessed outcomes after radical perineal prostatectomy. J Urol. 2007;178(2):488-492; discussion 492.
    • (2007) J Urol , vol.178 , Issue.2 , pp. 488-492
    • Kübler, H.R.1    Tseng, T.Y.2    Sun, L.3
  • 13
    • 33846846272 scopus 로고    scopus 로고
    • Brachytherapy versus prostatectomy in localized prostate cancer: Results of a French multicenter prospective medico-economic study
    • Buron C, Le Vu B, Cosset JM, et al. Brachytherapy versus prostatectomy in localized prostate cancer: results of a French multicenter prospective medico-economic study. Int J Radiat Oncol Biol Phys. 2007;67(3):812-822.
    • (2007) J Radiat Oncol Biol Phys , vol.67 , Issue.3 , pp. 812-822
    • Buron, C.1    Le Vu, B.2    Cosset, J.M.3
  • 14
    • 0642281442 scopus 로고    scopus 로고
    • Time course and predictors of symptoms after primary prostate cancer therapy
    • Talcott JA, Manola J, Clark JA, et al. Time course and predictors of symptoms after primary prostate cancer therapy. J Clin Oncol. 2003;21(21):3979-3986.
    • (2003) J Clin Oncol , vol.21 , Issue.21 , pp. 3979-3986
    • Talcott, J.A.1    Manola, J.2    Clark, J.A.3
  • 15
    • 0642281442 scopus 로고    scopus 로고
    • Time course and predictors of symptoms after primary prostate cancer therapy
    • Talcott JA, Manola J, Clark JA, et al. Time course and predictors of symptoms after primary prostate cancer therapy. J Clin Oncol. 2003;21(21):3979-3986.
    • (2003) J Clin Oncol , vol.21 , Issue.21 , pp. 3979-3986
    • Talcott, J.A.1    Manola, J.2    Clark, J.A.3
  • 16
    • 77957858051 scopus 로고    scopus 로고
    • Development of a patient-reported questionnaire for collecting toxicity data following prostate brachytherapy
    • Farnell D, Mandall P, Anandadas C, et al. Development of a patient-reported questionnaire for collecting toxicity data following prostate brachytherapy. Radiother Oncol. 2010;97(1):136-142.
    • (2010) Radiother Oncol , vol.97 , Issue.1 , pp. 136-142
    • Farnell, D.1    Mandall, P.2    Anandadas, C.3
  • 18
    • 0029071741 scopus 로고
    • Healthrelated quality of life in patients with advanced prostate cancer: A multinational perspective
    • Cleary PD, Morrissey G, Oster G. Healthrelated quality of life in patients with advanced prostate cancer: A multinational perspective. Qual Life Res. 1995;4(3):207-220.
    • (1995) Qual Life Res , vol.4 , Issue.3 , pp. 207-220
    • Cleary, P.D.1    Morrissey, G.2    Oster, G.3
  • 19
    • 69849095945 scopus 로고    scopus 로고
    • Individualizing quality-of-life outcomes reporting: How localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function
    • Chen RC, Clark JA, Talcott JA. Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function. J Clin Oncol. 2009;27(24):3916-3922.
    • (2009) J Clin Oncol , vol.27 , Issue.24 , pp. 3916-3922
    • Chen, R.C.1    Clark, J.A.2    Talcott, J.A.3
  • 20
    • 40949147326 scopus 로고    scopus 로고
    • Quality of life and satisfaction with outcome among prostate-cancer survivors
    • Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. New Engl J Med. 2008;358(12):1250-1261.
    • (2008) New Engl J Med , vol.358 , Issue.12 , pp. 1250-1261
    • Sanda, M.G.1    Dunn, R.L.2    Michalski, J.3
  • 21
    • 79953847139 scopus 로고    scopus 로고
    • Prostate size is not associated with recovery of sexual function after minimally invasive radical prostatectomy
    • Ward NT, Parsons JK, Levinson AW, et al. Prostate size is not associated with recovery of sexual function after minimally invasive radical prostatectomy. Urology. 2011;77(4):952-956.
    • (2011) Urology , vol.77 , Issue.4 , pp. 952-956
    • Ward, N.T.1    Parsons, J.K.2    Levinson, A.W.3
  • 22
    • 73349116538 scopus 로고    scopus 로고
    • Quality of life two years after radical prostatectomy, prostate brachytherapy or external beam radiotherapy for clinically localised prostate cancer: The Catalan Institute of Oncology/ Bellvitge Hospital experience
    • Guedea F, Ferrer M, Pera J, et al. Quality of life two years after radical prostatectomy, prostate brachytherapy or external beam radiotherapy for clinically localised prostate cancer: the Catalan Institute of Oncology/ Bellvitge Hospital experience. Clin Transl Oncol. 2009;11(7):470-478.
    • (2009) Clin Transl Oncol , vol.11 , Issue.7 , pp. 470-478
    • Guedea, F.1    Ferrer, M.2    Pera, J.3
  • 23
    • 0031449904 scopus 로고    scopus 로고
    • Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument
    • Esper P, Mo F, Chodak G, et al. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology. 1997;50(6):920-928.
    • (1997) Urology , vol.50 , Issue.6 , pp. 920-928
    • Esper, P.1    Mo, F.2    Chodak, G.3
  • 24
    • 4243094909 scopus 로고    scopus 로고
    • Brief assessment of priority symptoms in hormone refractory prostate cancer: The FACT Advanced Prostate Symptom Index (FAPSI)
    • Yount S, Cella D, Banik D, et al. Brief assessment of priority symptoms in hormone refractory prostate cancer: the FACT Advanced Prostate Symptom Index (FAPSI). Health Qual Life Outcomes. 2003;1:69.
    • (2003) Health Qual Life Outcomes , vol.1 , pp. 69
    • Yount, S.1    Cella, D.2    Banik, D.3
  • 25
    • 84861825229 scopus 로고    scopus 로고
    • Efficient assessment of the most important symptoms in advanced prostate cancer: The NCCN/FACT-P Symptom Index
    • Victorson DE, Beaumont JL, Rosenbloom SK, et al. Efficient assessment of the most important symptoms in advanced prostate cancer: the NCCN/FACT-P Symptom Index. Psychooncology. 2011;20(9):977-983.
    • (2011) Psychooncology , vol.20 , Issue.9 , pp. 977-983
    • Victorson, D.E.1    Beaumont, J.L.2    Rosenbloom, S.K.3
  • 26
    • 0037009822 scopus 로고    scopus 로고
    • A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma
    • Saad F, Gleason DM, Murray R, et al. A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. J Natl Cancer Inst. 2002;94(19):1458-1468.
    • (2002) J Natl Cancer Inst , vol.94 , Issue.19 , pp. 1458-1468
    • Saad, F.1    Gleason, D.M.2    Murray, R.3
  • 27
    • 78149356666 scopus 로고    scopus 로고
    • Zoledronic Acid improves clinical outcomes when administered before onset of bone pain in patients with prostate cancer
    • Saad F, Eastham J. Zoledronic Acid improves clinical outcomes when administered before onset of bone pain in patients with prostate cancer. Urology. 2010;76(5):1175-1181.
    • (2010) Urology , vol.76 , Issue.5 , pp. 1175-1181
    • Saad, F.1    Eastham, J.2
  • 28
    • 0141688330 scopus 로고    scopus 로고
    • Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain
    • Ernst DS, Tannock IF, Winquist EW, et al. Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain. J Clin Oncol. 2003;21(17):3335-3342.
    • (2003) J Clin Oncol , vol.21 , Issue.17 , pp. 3335-3342
    • Ernst, D.S.1    Tannock, I.F.2    Winquist, E.W.3
  • 29
    • 4744366279 scopus 로고    scopus 로고
    • Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
    • Tannock IF, de Wit R, Berry WR, et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med. 2004;351(15):1502-1512.
    • (2004) N Engl J Med , vol.351 , Issue.15 , pp. 1502-1512
    • Tannock, I.F.1    De Wit, R.2    Berry, W.R.3
  • 30
    • 33745570865 scopus 로고    scopus 로고
    • Quality of life and pain in advanced stage prostate cancer: Results of a Southwest Oncology Group randomized trial comparing docetaxel and estramustine to mitoxantrone and prednisone
    • Berry DL, Moinpour CM, Jiang CS, et al. Quality of life and pain in advanced stage prostate cancer: results of a Southwest Oncology Group randomized trial comparing docetaxel and estramustine to mitoxantrone and prednisone. J Clin Oncol. 2006;24(18):2828-2835.
    • (2006) J Clin Oncol , vol.24 , Issue.18 , pp. 2828-2835
    • Berry, D.L.1    Moinpour, C.M.2    Jiang, C.S.3
  • 31
    • 36849066178 scopus 로고    scopus 로고
    • Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institutesponsored clinical trials networks
    • Bruner DW, Bryan CJ, Aaronson N, et al. Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institutesponsored clinical trials networks. J Clin Oncol. 2007;25(32):5051-5057.
    • (2007) J Clin Oncol , vol.25 , Issue.32 , pp. 5051-5057
    • Bruner, D.W.1    Bryan, C.J.2    Aaronson, N.3
  • 32
    • 69849095945 scopus 로고    scopus 로고
    • Individualizing quality-of-life outcomes reporting: How localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function
    • Chen RC, Clark JA, Talcott JA. Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function. J Clin Oncol. 2009;27(24):3916-3922.
    • (2009) J Clin Oncol , vol.27 , Issue.24 , pp. 3916-3922
    • Chen, R.C.1    Clark, J.A.2    Talcott, J.A.3
  • 33
    • 78149272533 scopus 로고    scopus 로고
    • Qualityof-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment
    • Pardo Y, Guedea F, Aguiló F, et al. Qualityof-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment. J Clin Oncol. 2010;28(31):4687-4696.
    • (2010) J Clin Oncol , vol.28 , Issue.31 , pp. 4687-4696
    • Pardo, Y.1    Guedea, F.2    Aguiló, F.3
  • 34
    • 77950623573 scopus 로고    scopus 로고
    • Satisfaction with care: A measure of quality of care in prostate cancer patients
    • Jayadevappa R, Schwartz JS, Chhatre S, et al. Satisfaction with care: A measure of quality of care in prostate cancer patients. Med Decis Making. 2010;30(2):234-245.
    • (2010) Med Decis Making , vol.30 , Issue.2 , pp. 234-245
    • Jayadevappa, R.1    Schwartz, J.S.2    Chhatre, S.3
  • 35
    • 51449123875 scopus 로고    scopus 로고
    • Healthrelated quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer
    • Ferrer M, Suárez JF, Guedea F, et al. Healthrelated quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008;72(2):421-432.
    • (2008) J Radiat Oncol Biol Phys , vol.72 , Issue.2 , pp. 421-432
    • Ferrer, M.1    Suárez, J.F.2    Guedea, F.3
  • 36
    • 0141919741 scopus 로고    scopus 로고
    • Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer-data from CaPSURE
    • Downs TM, Sadetsky N, Pasta DJ, et al. Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer-data from CaPSURE. J Urol. 2003;170(5):1822-1827.
    • (2003) J Urol , vol.170 , Issue.5 , pp. 1822-1827
    • Downs, T.M.1    Sadetsky, N.2    Pasta, D.J.3
  • 37
    • 34248223102 scopus 로고    scopus 로고
    • An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer
    • Frank SJ, Pisters LL, Davis J, et al. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. J Urol. 2007;177(6):2151-2156; discussion 2156.
    • (2007) J Urol , vol.177 , Issue.6 , pp. 2151-2156
    • Frank, S.J.1    Pisters, L.L.2    Davis, J.3
  • 38
    • 32944478347 scopus 로고    scopus 로고
    • Geographic and socioeconomic variation in the treatment of prostate cancer
    • Krupski TL, Kwan L, Afifi AA, et al. Geographic and socioeconomic variation in the treatment of prostate cancer. J Clin Oncol. 2005;23(31):7881-7888.
    • (2005) J Clin Oncol , vol.23 , Issue.31 , pp. 7881-7888
    • Krupski, T.L.1    Kwan, L.2    Afifi, A.A.3
  • 39
    • 0037980149 scopus 로고    scopus 로고
    • Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation
    • Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41(5):582-592.
    • (2003) Med Care , vol.41 , Issue.5 , pp. 582-592
    • Norman, G.R.1    Sloan, J.A.2    Wyrwich, K.W.3
  • 40
    • 4644287961 scopus 로고    scopus 로고
    • Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: The prostate cancer outcomes study
    • Potosky AL, Davis WW, Hoffman RM, et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst. 2004;96(18):1358-1367.
    • (2004) J Natl Cancer Inst , vol.96 , Issue.18 , pp. 1358-1367
    • Potosky, A.L.1    Davis, W.W.2    Hoffman, R.M.3
  • 41
    • 0033013215 scopus 로고    scopus 로고
    • Convergent discriminitive, and predictive validity of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) assessment and comparison with analogous scales from the EORTC QLQ-C30 and a trial-specific module
    • European Organisation for Research and Treatment of Cancer. Core Quality of Life Questionnaire
    • Stockler MR, Osoba D, Corey P, et al. Convergent discriminitive, and predictive validity of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) assessment and comparison with analogous scales from the EORTC QLQ-C30 and a trial-specific module. European Organisation for Research and Treatment of Cancer. Core Quality of Life Questionnaire. J Clin Epidemiol. 1999;52(7):653-666.
    • (1999) J Clin Epidemiol , vol.52 , Issue.7 , pp. 653-666
    • Stockler, M.R.1    Osoba, D.2    Corey, P.3
  • 42
    • 17444430445 scopus 로고    scopus 로고
    • Reliability and validity of the PORPUS, a combined psychometric and utility-based quality-oflife instrument for prostate cancer
    • Ritvo P, Irvine J, Naglie G, et al. Reliability and validity of the PORPUS, a combined psychometric and utility-based quality-oflife instrument for prostate cancer. J Clin Epidemiol. 2005;58(5):466-474.
    • (2005) J Clin Epidemiol , vol.58 , Issue.5 , pp. 466-474
    • Ritvo, P.1    Irvine, J.2    Naglie, G.3
  • 43
    • 33845996971 scopus 로고    scopus 로고
    • Open versus laparoscopic radical prostatectomy: A prospective comparison of postoperative urinary incontinence rates
    • Jacobsen NE, Moore KN, Estey E, et al. Open versus laparoscopic radical prostatectomy: A prospective comparison of postoperative urinary incontinence rates. J Urol. 2007;177(2):615-619.
    • (2007) J Urol , vol.177 , Issue.2 , pp. 615-619
    • Jacobsen, N.E.1    Moore, K.N.2    Estey, E.3
  • 44
    • 34249091983 scopus 로고    scopus 로고
    • Urinary incontinence after radical prostatectomy: Can men at risk be identified preoperatively?
    • quiz 280-281
    • Moore KN, Truong V, Estey E, et al. Urinary incontinence after radical prostatectomy: can men at risk be identified preoperatively? J Wound Ostomy Continence Nurs. 2007;34(3):270-279; quiz 280-281.
    • (2007) J Wound Ostomy Continence Nurs , vol.34 , Issue.3 , pp. 270-279
    • Moore, K.N.1    Truong, V.2    Estey, E.3
  • 45
    • 0038287899 scopus 로고    scopus 로고
    • Measuring disease specific quality of life in localized prostate cancer: The Dutch experience
    • Korfage IJ, Essink-Bot ML, Madalinska JB, et al. Measuring disease specific quality of life in localized prostate cancer: the Dutch experience. Qual Life Res. 2003;12(4):459-464.
    • (2003) Qual Life Res , vol.12 , Issue.4 , pp. 459-464
    • Korfage, I.J.1    Essink-Bot, M.L.2    Madalinska, J.B.3
  • 46
    • 22044431995 scopus 로고    scopus 로고
    • Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer
    • Korfage IJ, Essink-Bot ML, Borsboom GJ, et al. Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer. Int J Cancer. 2005;116(2):291-296.
    • (2005) J Cancer , vol.116 , Issue.2 , pp. 291-296
    • Korfage, I.J.1    Essink-Bot, M.L.2    Borsboom, G.J.3
  • 47
    • 33748103704 scopus 로고    scopus 로고
    • Bringing prostate cancer quality of life research back to the bedside: Translating numbers into a format that patients can understand
    • discussion 1563-1564
    • Talcott JA, Clark JA, Manola J, et al. Bringing prostate cancer quality of life research back to the bedside: translating numbers into a format that patients can understand. J Urol. 2006;176(4 Pt 1):1558-1563; discussion 1563-1564.
    • (2006) J Urol , vol.176 , Issue.4 , pp. 1558-1563
    • Talcott, J.A.1    Clark, J.A.2    Manola, J.3
  • 48
    • 34249097462 scopus 로고    scopus 로고
    • Ethnic variation in return to baseline values of patient-reported outcomes in older prostate cancer patients
    • Jayadevappa R, Johnson JC, Chhatre S, et al. Ethnic variation in return to baseline values of patient-reported outcomes in older prostate cancer patients. Cancer. 2007;109(11):2229-2238.
    • (2007) Cancer , vol.109 , Issue.11 , pp. 2229-2238
    • Jayadevappa, R.1    Johnson, J.C.2    Chhatre, S.3
  • 49
    • 67449146839 scopus 로고    scopus 로고
    • Predictors of patient reported outcomes and cost of care in younger men with newly diagnosed prostate cancer
    • Jayadevappa R, Chhatre S, Wein AJ, et al. Predictors of patient reported outcomes and cost of care in younger men with newly diagnosed prostate cancer. Prostate. 2009;69(10):1067-1076.
    • (2009) Prostate , vol.69 , Issue.10 , pp. 1067-1076
    • Jayadevappa, R.1    Chhatre, S.2    Wein, A.J.3
  • 50
    • 77956027853 scopus 로고    scopus 로고
    • The burden of out-of-pocket and indirect costs of prostate cancer
    • Jayadevappa R, Schwartz JS, Chhatre S, et al. The burden of out-of-pocket and indirect costs of prostate cancer. Prostate. 2010;70(11):1255-1264.
    • (2010) Prostate , vol.70 , Issue.11 , pp. 1255-1264
    • Jayadevappa, R.1    Schwartz, J.S.2    Chhatre, S.3
  • 51
    • 0035045647 scopus 로고    scopus 로고
    • The association between socioeconomic status, health insurance coverage, and quality of life in men with prostate cancer
    • Penson DF, Stoddard ML, Pasta DJ, et al. The association between socioeconomic status, health insurance coverage, and quality of life in men with prostate cancer. J Clin Epidemiol. 2001;54(4):350-358.
    • (2001) J Clin Epidemiol , vol.54 , Issue.4 , pp. 350-358
    • Penson, D.F.1    Stoddard, M.L.2    Pasta, D.J.3
  • 52
    • 0141885276 scopus 로고    scopus 로고
    • Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: Results from CaPSURE
    • Mehta SS, Lubeck DP, Pasta DJ, et al. Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: results from CaPSURE. J Urol. 2003;170(5):1931-1933.
    • (2003) J Urol , vol.170 , Issue.5 , pp. 1931-1933
    • Mehta, S.S.1    Lubeck, D.P.2    Pasta, D.J.3
  • 53
    • 0347129585 scopus 로고    scopus 로고
    • Predicting quality of life after radical prostatectomy: Results from CaPSURE
    • discussion 707-708
    • Hu JC, Elkin EP, Pasta DJ, et al. Predicting quality of life after radical prostatectomy: results from CaPSURE. J Urol. 2004;171(2 Pt 1):703-707; discussion 707-708.
    • (2004) J Urol , vol.171 , Issue.2 , pp. 703-707
    • Hu, J.C.1    Elkin, E.P.2    Pasta, D.J.3
  • 54
    • 3142653152 scopus 로고    scopus 로고
    • Bowel function and bother after treatment for early stage prostate cancer: A longitudinal quality of life analysis from CaPSURE
    • Litwin MS, Sadetsky N, Pasta DJ, et al. Bowel function and bother after treatment for early stage prostate cancer: A longitudinal quality of life analysis from CaPSURE. J Urol. 2004;172(2):515-519.
    • (2004) J Urol , vol.172 , Issue.2 , pp. 515-519
    • Litwin, M.S.1    Sadetsky, N.2    Pasta, D.J.3
  • 55
    • 20144368522 scopus 로고    scopus 로고
    • The impact of obesity on health related quality of life before and after radical prostatectomy (data from CaPSURE)
    • Anast JW, Sadetsky N, Pasta DJ, et al. The impact of obesity on health related quality of life before and after radical prostatectomy (data from CaPSURE). J Urol. 2005;173(4):1132-1138.
    • (2005) J Urol , vol.173 , Issue.4 , pp. 1132-1138
    • Anast, J.W.1    Sadetsky, N.2    Pasta, D.J.3
  • 56
    • 33644757711 scopus 로고    scopus 로고
    • Impact of comorbidity on health-related quality of life in men undergoing radical prostatectomy: Data from CaPSURE
    • Arredondo SA, Elkin EP, Marr PL, et al. Impact of comorbidity on health-related quality of life in men undergoing radical prostatectomy: data from CaPSURE. Urology. 2006;67(3):559-565.
    • (2006) Urology , vol.67 , Issue.3 , pp. 559-565
    • Arredondo, S.A.1    Elkin, E.P.2    Marr, P.L.3
  • 57
    • 33845389629 scopus 로고    scopus 로고
    • Health-related quality of life for men with prostate cancer and diabetes: A longitudinal analysis from CaPSURE
    • Latini DM, Chan JM, Cowan JE, et al. Health-related quality of life for men with prostate cancer and diabetes: A longitudinal analysis from CaPSURE. Urology. 2006;68(6):1242-1247.
    • (2006) Urology , vol.68 , Issue.6 , pp. 1242-1247
    • Latini, D.M.1    Chan, J.M.2    Cowan, J.E.3
  • 58
    • 34247618655 scopus 로고    scopus 로고
    • Education predicts quality of life among men with prostate cancer cared for in the Department of Veterans Affairs: A longitudinal quality of life analysis from CaPSURE
    • Knight SJ, Latini DM, Hart SL, et al. Education predicts quality of life among men with prostate cancer cared for in the Department of Veterans Affairs: A longitudinal quality of life analysis from CaPSURE. Cancer. 2007;109(9):1769-1776.
    • (2007) Cancer , vol.109 , Issue.9 , pp. 1769-1776
    • Knight, S.J.1    Latini, D.M.2    Hart, S.L.3
  • 59
    • 56449084530 scopus 로고    scopus 로고
    • Fear of recurrence, symptom burden, and healthrelated quality of life in men with prostate cancer
    • Bellizzi KM, Latini DM, Cowan JE, et al. Fear of recurrence, symptom burden, and healthrelated quality of life in men with prostate cancer. Urology. 2008;72(6):1269-1273.
    • (2008) Urology , vol.72 , Issue.6 , pp. 1269-1273
    • Bellizzi, K.M.1    Latini, D.M.2    Cowan, J.E.3
  • 60
    • 39149101460 scopus 로고    scopus 로고
    • The impact of treatment choice for localized prostate cancer on response to phosphodiesterase inhibitors
    • discussion 1076
    • Lee IH, Sadetsky N, Carroll PR, et al. The impact of treatment choice for localized prostate cancer on response to phosphodiesterase inhibitors. J Urol. 2008;179(3):1072-1076; discussion 1076.
    • (2008) J Urol , vol.179 , Issue.3 , pp. 1072-1076
    • Lee, I.H.1    Sadetsky, N.2    Carroll, P.R.3
  • 61
    • 39449138799 scopus 로고    scopus 로고
    • Insurance and quality of life in men with prostate cancer: Data from the Cancer of the Prostate Strategic Urological Research Endeavor
    • Sadetsky N, Lubeck DP, Pasta DJ, et al. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor. BJU Int. 2008;101(6):691-697.
    • (2008) BJU Int , vol.101 , Issue.6 , pp. 691-697
    • Sadetsky, N.1    Lubeck, D.P.2    Pasta, D.J.3
  • 62
    • 48449105541 scopus 로고    scopus 로고
    • Severity of cardiovascular disease and health-related quality of life in men with prostate cancer: A longitudinal analysis from CaPSURE
    • van de Poll-Franse LV, Sadetsky N, Kwan L, et al. Severity of cardiovascular disease and health-related quality of life in men with prostate cancer: A longitudinal analysis from CaPSURE. Qual Life Res. 2008;17(6):845-855.
    • (2008) Qual Life Res , vol.17 , Issue.6 , pp. 845-855
    • Van De Poll-Franse, L.V.1    Sadetsky, N.2    Kwan, L.3
  • 63
    • 39149110308 scopus 로고    scopus 로고
    • Quality of life in young men after radical prostatectomy
    • Wright JL, Lin DW, Cowan JE, et al. Quality of life in young men after radical prostatectomy. Prostate Cancer Prostatic Dis. 2008;11(1):67-73.
    • (2008) Prostate Cancer Prostatic Dis , vol.11 , Issue.1 , pp. 67-73
    • Wright, J.L.1    Lin, D.W.2    Cowan, J.E.3
  • 64
    • 55549104351 scopus 로고    scopus 로고
    • Health related quality of life in patients treated with multimodal therapy for prostate cancer
    • discussion 2422
    • Wu AK, Cooperberg MR, Sadetsky N, et al. Health related quality of life in patients treated with multimodal therapy for prostate cancer. J Urol. 2008;180(6):2415-2422; discussion 2422.
    • (2008) J Urol , vol.180 , Issue.6 , pp. 2415-2422
    • Wu, A.K.1    Cooperberg, M.R.2    Sadetsky, N.3
  • 65
    • 70349230778 scopus 로고    scopus 로고
    • Predictive value of serial measurements of quality of life on all-cause mortality in prostate cancer patients: Data from CaPSURE (cancer of the prostate strategic urologic research endeavor) database
    • Sadetsky N, Hubbard A, Carroll PR, et al. Predictive value of serial measurements of quality of life on all-cause mortality in prostate cancer patients: data from CaPSURE (cancer of the prostate strategic urologic research endeavor) database. Qual Life Res. 2009;18(8):1019-1027.
    • (2009) Qual Life Res , vol.18 , Issue.8 , pp. 1019-1027
    • Sadetsky, N.1    Hubbard, A.2    Carroll, P.R.3
  • 66
    • 77956622408 scopus 로고    scopus 로고
    • Changes in specific domains of sexual function and sexual bother after radical prostatectomy
    • Le JD, Cooperberg MR, Sadetsky N, et al. Changes in specific domains of sexual function and sexual bother after radical prostatectomy. BJU Int. 2010;106(7):1022-1029.
    • (2010) BJU Int , vol.106 , Issue.7 , pp. 1022-1029
    • Le, J.D.1    Cooperberg, M.R.2    Sadetsky, N.3
  • 67
    • 78649333817 scopus 로고    scopus 로고
    • From bad to worse: Comorbidity severity and quality of life after treatment for earlystage prostate cancer
    • Daskivich TJ, van de Poll-Franse LV, Kwan L, et al. From bad to worse: comorbidity severity and quality of life after treatment for earlystage prostate cancer. Prostate Cancer Prostatic Dis. 2010;13(4):320-327.
    • (2010) Prostate Cancer Prostatic Dis , vol.13 , Issue.4 , pp. 320-327
    • Daskivich, T.J.1    Van De Poll-Franse, L.V.2    Kwan, L.3
  • 68
    • 77951615681 scopus 로고    scopus 로고
    • Impact of radical prostatectomy positive surgical margins on fear of cancer recurrence: Results from CaPSURE
    • Hong YM, Hu JC, Paciorek AT, et al. Impact of radical prostatectomy positive surgical margins on fear of cancer recurrence: results from CaPSURE. Urol Oncol. 2010;28(3):268-273.
    • (2010) Urol Oncol , vol.28 , Issue.3 , pp. 268-273
    • Hong, Y.M.1    Hu, J.C.2    Paciorek, A.T.3
  • 69
    • 77951877467 scopus 로고    scopus 로고
    • Health related quality of life for men treated for localized prostate cancer with long-term followup
    • Huang GJ, Sadetsky N, Penson DF. Health related quality of life for men treated for localized prostate cancer with long-term followup. J Urol. 2010;183(6):2206-2212.
    • (2010) J Urol , vol.183 , Issue.6 , pp. 2206-2212
    • Huang, G.J.1    Sadetsky, N.2    Penson, D.F.3
  • 70
    • 80052943921 scopus 로고    scopus 로고
    • Impact of androgen deprivation on physical well-being in patients with prostate cancer: Analysis from the CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) registry
    • Sadetsky N, Greene K, Cooperberg MR, et al. Impact of androgen deprivation on physical well-being in patients with prostate cancer: Analysis from the CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) registry. Cancer. 2011;117(19):4406-4413.
    • (2011) Cancer , vol.117 , Issue.19 , pp. 4406-4413
    • Sadetsky, N.1    Greene, K.2    Cooperberg, M.R.3
  • 71
    • 33745807290 scopus 로고    scopus 로고
    • Natural history of voiding function after radical retropubic prostatectomy
    • Namiki S, Ishidoya S, Saito S, et al. Natural history of voiding function after radical retropubic prostatectomy. Urology. 2006;68(1):142-147.
    • (2006) Urology , vol.68 , Issue.1 , pp. 142-147
    • Namiki, S.1    Ishidoya, S.2    Saito, S.3
  • 72
    • 33947255974 scopus 로고    scopus 로고
    • Impact of salvage therapy for biochemical recurrence on health-related quality of life following radical prostatectomy
    • Namiki S, Saito S, Tochigi T, et al. Impact of salvage therapy for biochemical recurrence on health-related quality of life following radical prostatectomy. Int J Urol. 2007;14(3):186-191.
    • (2007) J Urol , vol.14 , Issue.3 , pp. 186-191
    • Namiki, S.1    Saito, S.2    Tochigi, T.3
  • 73
    • 50649116337 scopus 로고    scopus 로고
    • Sexual function following radical prostatectomy: A prospective longitudinal study of cultural differences between Japanese and American men
    • Namiki S, Kwan L, Kagawa-Singer M, et al. Sexual function following radical prostatectomy: A prospective longitudinal study of cultural differences between Japanese and American men. Prostate Cancer Prostatic Dis. 2008;11(3):298-302.
    • (2008) Prostate Cancer Prostatic Dis , vol.11 , Issue.3 , pp. 298-302
    • Namiki, S.1    Kwan, L.2    Kagawa-Singer, M.3
  • 74
    • 44649170275 scopus 로고    scopus 로고
    • Urinary quality of life after prostatectomy or radiation for localized prostate cancer: A prospective longitudinal cross-cultural study between Japanese and U.S
    • Namiki S, Kwan L, Kagawa-Singer M, et al. Urinary quality of life after prostatectomy or radiation for localized prostate cancer: A prospective longitudinal cross-cultural study between Japanese and U.S. men. Urology. 2008;71(6):1103-1108.
    • (2008) Men. Urology , vol.71 , Issue.6 , pp. 1103-1108
    • Namiki, S.1    Kwan, L.2    Kagawa-Singer, M.3
  • 75
    • 60349098738 scopus 로고    scopus 로고
    • Distress and social dysfunction following prostate cancer treatment: A longitudinal cross-cultural comparison of Japanese and American men
    • Namiki S, Kwan L, Kagawa-Singer M, et al. Distress and social dysfunction following prostate cancer treatment: A longitudinal cross-cultural comparison of Japanese and American men. Prostate Cancer Prostatic Dis. 2009;12(1):67-71.
    • (2009) Prostate Cancer Prostatic Dis , vol.12 , Issue.1 , pp. 67-71
    • Namiki, S.1    Kwan, L.2    Kagawa-Singer, M.3
  • 76
    • 77449123030 scopus 로고    scopus 로고
    • Quality of life among elderly men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy
    • Namiki S, Ishidoya S, Kawamura S, et al. Quality of life among elderly men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy. J Cancer Res Clin Oncol. 2010;136(3):379-386.
    • (2010) J Cancer Res Clin Oncol , vol.136 , Issue.3 , pp. 379-386
    • Namiki, S.1    Ishidoya, S.2    Kawamura, S.3
  • 77
    • 80053065502 scopus 로고    scopus 로고
    • Prediction of erectile function following treatment for prostate cancer
    • Alemozaffar M, Regan MM, Cooperberg MR, et al. Prediction of erectile function following treatment for prostate cancer. JAMA. 2011;306(11):1205-1214.
    • (2011) JAMA , vol.306 , Issue.11 , pp. 1205-1214
    • Alemozaffar, M.1    Regan, M.M.2    Cooperberg, M.R.3
  • 78
    • 67449168040 scopus 로고    scopus 로고
    • Impact of cancer on health-related quality of life of older Americans
    • Reeve BB, Potosky AL, Smith AW, et al. Impact of cancer on health-related quality of life of older Americans. J Natl Cancer Inst. 2009;101(12):860-868.
    • (2009) J Natl Cancer Inst , vol.101 , Issue.12 , pp. 860-868
    • Reeve, B.B.1    Potosky, A.L.2    Smith, A.W.3
  • 79
    • 0141894176 scopus 로고    scopus 로고
    • Improving quality of life in men with prostate cancer: A randomized controlled trial of group education interventions
    • Lepore SJ, Helgeson VS, Eton DT, et al. Improving quality of life in men with prostate cancer: A randomized controlled trial of group education interventions. Health Psychol. 2003;22(5):443-452.
    • (2003) Health Psychol , vol.22 , Issue.5 , pp. 443-452
    • Lepore, S.J.1    Helgeson, V.S.2    Eton, D.T.3
  • 80
    • 37049023701 scopus 로고    scopus 로고
    • Randomized clinical trial of a family intervention for prostate cancer patients and their spouses
    • Northouse LL, Mood DW, Schafenacker A, et al. Randomized clinical trial of a family intervention for prostate cancer patients and their spouses. Cancer. 2007;110(12):2809-2818.
    • (2007) Cancer , vol.110 , Issue.12 , pp. 2809-2818
    • Northouse, L.L.1    Mood, D.W.2    Schafenacker, A.3
  • 81
    • 37849036818 scopus 로고    scopus 로고
    • Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy
    • Moinpour CM, Hayden KA, Unger JM, et al. Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy. J Clin Oncol. 2008;26(1):112-120.
    • (2008) J Clin Oncol , vol.26 , Issue.1 , pp. 112-120
    • Moinpour, C.M.1    Hayden, K.A.2    Unger, J.M.3
  • 82
    • 67149125847 scopus 로고    scopus 로고
    • Duration of androgen suppression in the treatment of prostate cancer
    • Bolla M, de Reijke TM, Van Tienhoven G, et al. Duration of androgen suppression in the treatment of prostate cancer. N Engl J Med. 2009;360(24):2516-2527.
    • (2009) N Engl J Med , vol.360 , Issue.24 , pp. 2516-2527
    • Bolla, M.1    De Reijke, T.M.2    Van Tienhoven, G.3
  • 83
    • 63149192727 scopus 로고    scopus 로고
    • Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/ SFUO-3, an open-label, randomised, phase III trial
    • Fransson P, Lund JA, Damber JE, et al. Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/ SFUO-3, an open-label, randomised, phase III trial. Lancet Oncol. 2009;10(4):370-380.
    • (2009) Lancet Oncol , vol.10 , Issue.4 , pp. 370-380
    • Fransson, P.1    Lund, J.A.2    Damber, J.E.3
  • 84
    • 65549163328 scopus 로고    scopus 로고
    • Effects of home-based diet and exercise on functional outcomes among older, overweight long-term cancer survivors: RENEW: A randomized controlled trial
    • Morey MC, Snyder DC, Sloane R, et al. Effects of home-based diet and exercise on functional outcomes among older, overweight long-term cancer survivors: RENEW: A randomized controlled trial. JAMA. 2009;301(18):1883-1891.
    • (2009) JAMA , vol.301 , Issue.18 , pp. 1883-1891
    • Morey, M.C.1    Snyder, D.C.2    Sloane, R.3
  • 85
    • 77951665730 scopus 로고    scopus 로고
    • Reduction in patient-reported acute morbidity in prostate cancer patients treated with 81-Gy Intensity-modulated radiotherapy using reduced planning target volume margins and electromagnetic tracking: Assessing the impact of margin reduction study
    • Sandler HM, Liu PY, Dunn RL, et al. Reduction in patient-reported acute morbidity in prostate cancer patients treated with 81-Gy Intensity-modulated radiotherapy using reduced planning target volume margins and electromagnetic tracking: Assessing the impact of margin reduction study. Urology. 2010;75(5):1004-1008.
    • (2010) Urology , vol.75 , Issue.5 , pp. 1004-1008
    • Sandler, H.M.1    Liu, P.Y.2    Dunn, R.L.3
  • 86
    • 83955165856 scopus 로고    scopus 로고
    • Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: A randomised, phase 3 trial
    • Warde P, Mason M, Ding K, et al. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: A randomised, phase 3 trial. Lancet. 2011;378(9809):2104-2111.
    • (2011) Lancet , vol.378 , Issue.9809 , pp. 2104-2111
    • Warde, P.1    Mason, M.2    Ding, K.3
  • 87
    • 79951952326 scopus 로고    scopus 로고
    • Dose escalation and quality of life in patients with localized prostate cancer treated with radiotherapy: Long-term results of the Dutch randomized dose-escalation trial (CKTO 96-10 trial)
    • Al-Mamgani A, van Putten WL, van der Wielen GJ, et al. Dose escalation and quality of life in patients with localized prostate cancer treated with radiotherapy: long-term results of the Dutch randomized dose-escalation trial (CKTO 96-10 trial). Int J Radiat Oncol Biol Phys. 2011;79(4):1004-1012.
    • (2011) J Radiat Oncol Biol Phys , vol.79 , Issue.4 , pp. 1004-1012
    • Al-Mamgani, A.1    Van Putten, W.L.2    Van Der Wielen, G.J.3
  • 88
    • 79959335126 scopus 로고    scopus 로고
    • 70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial
    • Beckendorf V, Guerif S, Le Prisé E, et al. 70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial. Int J Radiat Oncol Biol Phys. 2011;80(4):1056-1063.
    • (2011) J Radiat Oncol Biol Phys , vol.80 , Issue.4 , pp. 1056-1063
    • Beckendorf, V.1    Guerif, S.2    Le Prisé, E.3
  • 89
    • 33746387985 scopus 로고    scopus 로고
    • Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer
    • Spry NA, Kristjanson L, Hooton B, et al. Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer. Eur J Cancer. 2006;42(8):1083-1092.
    • (2006) Eur J Cancer , vol.42 , Issue.8 , pp. 1083-1092
    • Spry, N.A.1    Kristjanson, L.2    Hooton, B.3
  • 90
    • 33947519066 scopus 로고    scopus 로고
    • Quality of life findings from a multicenter, multinational, observational study of patients with metastatic hormone-refractory prostate cancer
    • Sullivan PW, Mulani PM, Fishman M, et al. Quality of life findings from a multicenter, multinational, observational study of patients with metastatic hormone-refractory prostate cancer. Qual Life Res. 2007;16(4):571-575.
    • (2007) Qual Life Res , vol.16 , Issue.4 , pp. 571-575
    • Sullivan, P.W.1    Mulani, P.M.2    Fishman, M.3
  • 91
    • 34548584066 scopus 로고    scopus 로고
    • Effects of skeletal morbidities on longitudinal patientreported outcomes and survival in patients with metastatic prostate cancer
    • DePuy V, Anstrom KJ, Castel LD, et al. Effects of skeletal morbidities on longitudinal patientreported outcomes and survival in patients with metastatic prostate cancer. Support Care Cancer. 2007;15(7):869-876.
    • (2007) Support Care Cancer , vol.15 , Issue.7 , pp. 869-876
    • Depuy, V.1    Anstrom, K.J.2    Castel, L.D.3
  • 92
    • 0037441843 scopus 로고    scopus 로고
    • Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: A randomized, phase II, placebo-controlled trial
    • Carducci MA, Padley RJ, Breul J, et al. Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: A randomized, phase II, placebo-controlled trial. J Clin Oncol. 2003;21(4):679-689.
    • (2003) J Clin Oncol , vol.21 , Issue.4 , pp. 679-689
    • Carducci, M.A.1    Padley, R.J.2    Breul, J.3
  • 93
    • 33750564275 scopus 로고    scopus 로고
    • Quality of life as a potential predictor for morbidity and mortality in patients with metastatic hormone-refractory prostate cancer
    • Sullivan PW, Nelson JB, Mulani PM, et al. Quality of life as a potential predictor for morbidity and mortality in patients with metastatic hormone-refractory prostate cancer. Qual Life Res. 2006;15(8):1297-1306.
    • (2006) Qual Life Res , vol.15 , Issue.8 , pp. 1297-1306
    • Sullivan, P.W.1    Nelson, J.B.2    Mulani, P.M.3
  • 94
    • 58849115091 scopus 로고    scopus 로고
    • Estimating clinically meaningful changes for the Functional Assessment of Cancer Therapy-Prostate: Results from a clinical trial of patients with metastatic hormonerefractory prostate cancer
    • Cella D, Nichol MB, Eton D, et al. Estimating clinically meaningful changes for the Functional Assessment of Cancer Therapy-Prostate: results from a clinical trial of patients with metastatic hormonerefractory prostate cancer. Value Health. 2009;12(1):124-129.
    • (2009) Value Health , vol.12 , Issue.1 , pp. 124-129
    • Cella, D.1    Nichol, M.B.2    Eton, D.3
  • 95
    • 49649115490 scopus 로고    scopus 로고
    • Treatment of hormone-refractory prostate cancer with docetaxel or mitoxantrone: Relationships between prostate-specific antigen, pain, and quality of life response and survival in the TAX-327 study
    • Berthold DR, Pond GR, Roessner M, et al. Treatment of hormone-refractory prostate cancer with docetaxel or mitoxantrone: relationships between prostate-specific antigen, pain, and quality of life response and survival in the TAX-327 study. Clin Cancer Res. 2008;14(9):2763-2767.
    • (2008) Clin Cancer Res , vol.14 , Issue.9 , pp. 2763-2767
    • Berthold, D.R.1    Pond, G.R.2    Roessner, M.3
  • 96
    • 54949159478 scopus 로고    scopus 로고
    • Evaluation of quality of life in patients with previously untreated advanced prostate cancer receiving maximum androgen blockade therapy or LHRHa monotherapy: A multicenter, randomized, double-blind, comparative study
    • Arai Y, Akaza H, Deguchi T, et al. Evaluation of quality of life in patients with previously untreated advanced prostate cancer receiving maximum androgen blockade therapy or LHRHa monotherapy: A multicenter, randomized, double-blind, comparative study. J Cancer Res Clin Oncol. 2008;134(12):1385-1396.
    • (2008) J Cancer Res Clin Oncol , vol.134 , Issue.12 , pp. 1385-1396
    • Arai, Y.1    Akaza, H.2    Deguchi, T.3
  • 97
    • 65049090443 scopus 로고    scopus 로고
    • Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: Results from a randomised phase 3 study of the South European Uroncological Group
    • Calais da Silva FE, Bono AV, Whelan P, et al. Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3 study of the South European Uroncological Group. Eur Urol. 2009;55(6):1269-1277.
    • (2009) Eur Urol , vol.55 , Issue.6 , pp. 1269-1277
    • Calais Da Silva, F.E.1    Bono, A.V.2    Whelan, P.3
  • 98
    • 79951678465 scopus 로고    scopus 로고
    • A multicentre randomised phase III trial of dexamethasone vs dexamethasone and diethylstilbestrol in castration-resistant prostate cancer: Immediate vs deferred diethylstilbestrol
    • Shamash J, Powles T, Sarker SJ, et al. A multicentre randomised phase III trial of dexamethasone vs dexamethasone and diethylstilbestrol in castration-resistant prostate cancer: immediate vs deferred diethylstilbestrol. Br J Cancer. 2011;104(4):620-628.
    • (2011) Br J Cancer , vol.104 , Issue.4 , pp. 620-628
    • Shamash, J.1    Powles, T.2    Sarker, S.J.3
  • 99
    • 0030885716 scopus 로고    scopus 로고
    • Dimensions of quality of life expressed by men treated for metastatic prostate cancer
    • Clark JA, Wray N, Brody B, et al. Dimensions of quality of life expressed by men treated for metastatic prostate cancer. Soc Sci Med. 1997;45(8):1299-1309.
    • (1997) Soc Sci Med , vol.45 , Issue.8 , pp. 1299-1309
    • Clark, J.A.1    Wray, N.2    Brody, B.3
  • 100
    • 0041379801 scopus 로고    scopus 로고
    • Measuring patients' perceptions of the outcomes of treatment for early prostate cancer
    • Clark JA, Bokhour BG, Inui TS, et al. Measuring patients' perceptions of the outcomes of treatment for early prostate cancer. Med Care. 2003;41(8):923-936.
    • (2003) Med Care , vol.41 , Issue.8 , pp. 923-936
    • Clark, J.A.1    Bokhour, B.G.2    Inui, T.S.3
  • 101
    • 0033965762 scopus 로고    scopus 로고
    • An instrument to measure patient satisfaction with healthcare in an observational database: Results of a validation study using data from CaPSURE
    • Lubeck DP, Litwin MS, Henning JM, et al. An instrument to measure patient satisfaction with healthcare in an observational database: results of a validation study using data from CaPSURE. Am J Manag Care. 2000;6(1):70-76.
    • (2000) Am J Manag Care , vol.6 , Issue.1 , pp. 70-76
    • Lubeck, D.P.1    Litwin, M.S.2    Henning, J.M.3
  • 102
    • 0037507343 scopus 로고    scopus 로고
    • The memorial anxiety scale for prostate cancer: Validation of a new scale to measure anxiety in men with with prostate cancer
    • AJ, Rosenfeld B, Kornblith AB, et al. The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer. Cancer. 2003;97(11):2910-2918
    • (2003) Cancer , vol.97 , Issue.11 , pp. 2910-2918
    • Roth, A.J.1    Rosenfeld, B.2    Kornblith, A.B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.